May 11, 2010
The FDA's Division of Drug Marketing, Advertising, and Communications (DDMAC) has launched the Bad Ad Program, designed to educate healthcare providers about their role in ensuring that prescription drug advertising and promotion is truthful, and not misleading.
March 22, 2010
Galderma's Differin product line has been expanded with the FDA approval of Differin Lotion (adapalene lotion) 0.1% for the treatment of acne vulgaris in patients ≥12 years of age.
February 03, 2010
The FDA has approved Medicis' hyaluronic acid with lidocaine dermal fillers, Restylane-L and Perlane-L.
February 02, 2010
The FDA has approved Juvéderm XC (hyaluronic acid and lidocaine [preservative-free] injectable gel, from Allergan) dermal filler for injection into the mid-to-deep dermis for correction of moderate to severe facial wrinkles and folds (eg, nasolabial folds).
October 01, 2009
Onset Therapeutics has launched BenzEFoam (benzoyl peroxide 5.3%) emollient foam for the topical treatment of mild to moderate acne vulgaris.